These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 1998366)

  • 41. Delays in diagnosis and melanoma prognosis (I): the role of patients.
    Richard MA; Grob JJ; Avril MF; Delaunay M; Gouvernet J; Wolkenstein P; Souteyrand P; Dreno B; Bonerandi JJ; Dalac S; Machet L; Guillaume JC; Chevrant-Breton J; Vilmer C; Aubin F; Guillot B; Beylot-Barry M; Lok C; Raison-Peyron N; Chemaly P
    Int J Cancer; 2000 May; 89(3):271-9. PubMed ID: 10861504
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Unrecognized sex-specific stress and behavior differences in patients with melanoma.
    Grichnik JM
    Arch Dermatol; 2011 Feb; 147(2):186. PubMed ID: 21339446
    [No Abstract]   [Full Text] [Related]  

  • 43. Help-seeking habits of untreated leprosy patients reporting to a referral hospital in Uttar Pradesh, India.
    Samraj A; Kaki S; Rao PS
    Indian J Lepr; 2012; 84(2):123-9. PubMed ID: 23236699
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Awareness and early detection of cutaneous melanoma: an analysis of factors related to delay in treatment.
    Blum A; Brand CU; Ellwanger U; Schlagenhauff B; Stroebel W; Rassner G; Garbe C
    Br J Dermatol; 1999 Nov; 141(5):783-7. PubMed ID: 10583157
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Delay in the diagnosis of cutaneous malignant melanoma. A prospective study in 250 patients.
    Krige JE; Isaacs S; Hudson DA; King HS; Strover RM; Johnson CA
    Cancer; 1991 Nov; 68(9):2064-8. PubMed ID: 1913555
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Screening for melanoma: a community survey of prevalence and predictors.
    Girgis A; Campbell EM; Redman S; Sanson-Fisher RW
    Med J Aust; 1991 Mar; 154(5):338-43. PubMed ID: 2017062
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Unexpected telephone call informed about malignant melanoma].
    Brandberg Y; Bolund C; Månsson-Brahme E; Ringborg U; Sjödén PO
    Lakartidningen; 1991 Sep; 88(36):2907-9. PubMed ID: 1895845
    [No Abstract]   [Full Text] [Related]  

  • 48. Factors related to patient delay in seeking medical attention for cutaneous malignant melanoma.
    Temoshok L; DiClemente RJ; Sweet DM; Blois MS; Sagebiel RW
    Cancer; 1984 Dec; 54(12):3048-53. PubMed ID: 6498779
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Time to diagnosis of melanoma: same trend in different continents.
    Blum A; Ingvar C; Avramidis M; von Kannen A; Menzies SW; Olsson H; Rezze GG; Wennberg AM; Westerhoff K
    J Cutan Med Surg; 2007; 11(4):137-44. PubMed ID: 17601421
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Visual discrimination of pigmented skin lesions.
    Miles F; Meehan JW
    Health Psychol; 1995 Mar; 14(2):171-7. PubMed ID: 7789353
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Delay in consulting a medical practitioner about rectal bleeding.
    Byles JE; Redman S; Hennrikus D; Sanson-Fisher RW; Dickinson J
    J Epidemiol Community Health; 1992 Jun; 46(3):241-4. PubMed ID: 1645079
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Psychological reactions in public melanoma screening.
    Brandberg Y; Bolund C; Michelson H; Månsson-Brahme E; Ringborg U; Sjödén PO
    Eur J Cancer; 1993; 29A(6):860-3. PubMed ID: 8484978
    [TBL] [Abstract][Full Text] [Related]  

  • 53. GPs have role in early detection of melanoma.
    Holme SA
    Practitioner; 2013 Jun; 257(1762):27-30, 3. PubMed ID: 23905286
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Which symptoms are linked to a delayed presentation among melanoma patients? A retrospective study.
    O'Shea SJ; Rogers Z; Warburton F; Ramirez AJ; Newton-Bishop JA; Forbes LJ
    BMC Cancer; 2017 Jan; 17(1):5. PubMed ID: 28049453
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Community perceptions about the important signs of early melanoma.
    Baade PD; Balanda KP; Stanton WR; Gillespie AM; Lowe JB
    J Am Acad Dermatol; 1997 Jan; 36(1):33-9. PubMed ID: 8996258
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Are young adults checking their skin for melanoma?
    Douglass HM; McGee R; Williams S
    Aust N Z J Public Health; 1998 Aug; 22(5):562-7. PubMed ID: 9744210
    [TBL] [Abstract][Full Text] [Related]  

  • 57. "Catalyst" symptoms in malignant melanoma.
    Cassileth BR; Lusk EJ; Guerry D; Clark WH; Matozzo I; Frederick BE
    J Gen Intern Med; 1987; 2(1):1-4. PubMed ID: 3806266
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Time delays and related factors in the diagnosis of cutaneous melanoma.
    Brochez L; Verhaeghe E; Bleyen L; Naeyaert JM
    Eur J Cancer; 2001 May; 37(7):843-8. PubMed ID: 11313171
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [How to announce the diagnosis for melanoma?].
    Charles C; Rouby P; Robert C
    Rev Prat; 2014 Jan; 64(1):55-6, 59-60. PubMed ID: 24649547
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Overscreening and underscreening for melanoma: comment on "the influence of age and sex on reasons for seeking and expected benefits of skin cancer screening".
    Stratman EJ
    Arch Dermatol; 2010 Oct; 146(10):1102. PubMed ID: 20956640
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.